These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 852499)

  • 1. The evolution of the regulatory framework for the plasma and plasma-derived medicinal products system in Italy.
    Calizzani G; Vaglio S; Candura F; Profili S; Lanzoni M; Cristiano K; Tamburrini MR; Grazzini G; Oleari F
    Blood Transfus; 2013 Sep; 11 Suppl 4(Suppl 4):s6-12. PubMed ID: 24333315
    [No Abstract]   [Full Text] [Related]  

  • 2. Once is not enough.
    Gross F
    Eur J Clin Pharmacol; 1977; 11(5):323-4. PubMed ID: 880970
    [No Abstract]   [Full Text] [Related]  

  • 3. Uses and limitations of primates in the evaluation of drug efficacy and safety.
    Dayan AD
    J R Soc Med; 1978 Sep; 71(9):691-2. PubMed ID: 712749
    [No Abstract]   [Full Text] [Related]  

  • 4. [Trend reversal in drug research].
    Thesing J
    Naturwissenschaften; 1977 Dec; 64(12):601-5. PubMed ID: 593414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constraints of drug regulation on the development of new drugs.
    Gross F
    Arch Toxicol; 1979 Oct; 43(1):9-17. PubMed ID: 533368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicological barriers to providing better drugs.
    Lasagna L
    Arch Toxicol; 1979 Oct; 43(1):27-33. PubMed ID: 533359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS drugs & the pharmaceutical industry: a need for reform.
    Griffin MT
    Am J Law Med; 1991; 17(4):363-410. PubMed ID: 1812767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug evaluation: new requirements and perspectives].
    Addis A; Rocchi F
    Recenti Prog Med; 2006 Nov; 97(11):618-25. PubMed ID: 17252718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and safety aspects of existing requirements and regulations when introducing a new drug.
    Kramer M
    Arzneimittelforschung; 1974 Apr; 24(4):504-8. PubMed ID: 4408328
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug metabolism: an industrial research view of the future.
    Ober RE
    Drug Metab Rev; 1979; 10(2):315-9. PubMed ID: 551917
    [No Abstract]   [Full Text] [Related]  

  • 11. Developing a European framework for research on children's medicines: an examination of the proposed EU regulation on medicinal products for paediatric use.
    Seyberth HW; Demotes-Mainard J; Wrobel P
    Pediatr Nephrol; 2005 Nov; 20(11):1537-40. PubMed ID: 16167134
    [No Abstract]   [Full Text] [Related]  

  • 12. [Metabolism of drugs and drug security].
    Rentsch GA
    Dtsch Med Wochenschr; 1975 Oct; 100(44):2285-92. PubMed ID: 1183328
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research of for the discovery of new drugs and research for the development and production of drugs].
    Setnikar I
    Boll Chim Farm; 1971 Sep; 110(9):503-9. PubMed ID: 5137987
    [No Abstract]   [Full Text] [Related]  

  • 14. Towards a more rational regulation of the development of new medicines. Report of a European workshop held in Sestri Levante, Italy, September 28-30, 1976.
    Eur J Clin Pharmacol; 1977 Mar; 11(3):233-8. PubMed ID: 852499
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.